Health ❯Healthcare ❯Pharmaceuticals

Weight Loss

GLP-1 Drugs Obesity Treatments Wegovy Semaglutide GLP-1 Receptor Agonists GLP-1 Medications Clinical Trials Obesity Treatment Mounjaro Amycretin

52 ARTICLES

3w ago

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Priced from ₹17,345 to ₹26,050 per month, the weekly semaglutide injection targets $1 billion in sales over seven years, facing growing competition as its patent nears expiry.

4 ARTICLES

3w ago

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

13 ARTICLES

last mo.

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

3 ARTICLES

last mo.

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

13 ARTICLES

2mo ago

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

7 ARTICLES

4mo ago

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

7 ARTICLES

5mo ago

Super Bowl Ad for Compounded Weight Loss Drugs Draws Criticism Over Safety and Regulation

6 ARTICLES

6mo ago

Warnings Issued Over Unsafe Online Sales of Weight-Loss Injections

4 ARTICLES

6mo ago

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

19 ARTICLES

6mo ago

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

3 ARTICLES

7mo ago

Eli Lilly Partners with Ro to Expand Access to Lower-Cost Zepbound Vials

24 ARTICLES

7mo ago

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

13 ARTICLES

7mo ago

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

Particle.news

Weight Loss

Novo Nordisk Launches Wegovy Weight-Loss Drug in India

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

Trump's Executive Order Targets U.S. Drug Price Disparities

Weight Management Revolution: GLP-1 Drugs Dominate as Pills Emerge

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

Novo Nordisk Partners with Telehealth Firms to Expand Wegovy Access

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

Hims & Hers Expands Weight-Loss Offerings with New Medications

Never miss stories about

Weight Loss

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Super Bowl Ad for Compounded Weight Loss Drugs Draws Criticism Over Safety and Regulation

Warnings Issued Over Unsafe Online Sales of Weight-Loss Injections

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Novo Nordisk Shares Plunge After Weight-Loss Drug Trial Falls Short

Eli Lilly Partners with Ro to Expand Access to Lower-Cost Zepbound Vials

Zepbound Outperforms Wegovy in Weight Loss Clinical Trial

NHS to Gradually Roll Out Mounjaro Weight-Loss Drug Over 12 Years

Never miss stories about

Weight Loss